Acne Vulgaris study: Active CAP therapy
Official title Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study
ClinicalTrials.gov ID: NCT07056673
What this study is testing
- What it's testing
- The study wants to see if these plasma devices can help clear acne and if they are safe to use.
- Who it's for
- It is looking for adults who have moderate or severe acne that has not responded well to usual treatments.
- What's involved
- Participants will use the plasma devices at home and attend clinic visits for skin checks and safety monitoring. They may also receive standard acne care as needed.
- Time commitment
- The study lasts several months, with regular clinic visits and daily use of the device at home.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Aged 18-40 years;
- Clinically diagnosed with acne vulgaris, with moderate to severe disease (Pillsbury grade III or IV, lesion count ≥50);
- Will agree to use effective contraception during the treatment period;
- Will sign a written informed consent form.
You likely can't join if
- Pregnant or breastfeeding women;
- Known allergy to any active component of CAP;
- Use of systemic antibiotics within 4 weeks prior to enrollment;
- Presence of dyslipidemia or other severe systemic diseases;
- Participation in other clinical trials within the past 3 months or currently enrolled in another clinical trial.
The study team makes the final eligibility decision.
Where it is enrolling
- Luoyang, Henan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Luoyang, Henan, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.